Join        Login             Stock Quote

Heartware International (HTWR) Guides Q4, FY Revenue Above Estimates

 January 07, 2013 02:10 PM

(By Balachander) HeartWare International Inc. (NASDAQ: HTWR), a maker of ventricular assist devices to treat advanced heart failure, issued its revenue guidance for the fourth quarter and full year that were above market expectations.

The company expects total revenue for the fourth quarter and full year to be roughly $32 million and $110 million, respectively.

Wall Street analysts, on average, expect revenue of $27.76 million and $106.07 million for the three-month period and 2012, respectively.

HeartWare said the results reflect positive initial trends in the commercial launch of the HeartWare Ventricular Assist System in the U.S., as around 40 percent of fourth-quarter revenue were generated from domestic sales.

[Related -Stocks End Higher On Data; Nuance (NUAN) Plunges]

In addition, the company said it remains optimistic about long-term global market growth prospects and its role in stimulating that growth.

"This sentiment is bolstered by our observed revenue growth of approximately 40 percent in the fourth quarter over the fourth quarter of 2011, and approximately 33 percent growth in full-year 2012 revenues over 2011," HeartWare added.

The company's HeartWare Ventricular Assist System features the HVAD pump, a small full-support circulatory assist device designed to be implanted next to the heart, avoiding the abdominal surgery generally required to implant competing devices.

HTWR shares dipped 0.17 percent to trade at $89.48. Over the past year, the stock has been trading between $61.00 and $97.31.

iOnTheMarket Premium


Post Comment -- Login is required to post message
Alert for new comments:
Your email:
Your Website:

rss feed

Latest Stories

article imageUS REITs Edged Higher Last Week As Emerging Markets Slumped

Real estate investment trusts (REITs) in the US took the lead in last week’s shortened holiday trading week read on...

article imageA Contrarian Perspective On The Short EuroTtrade

As the euro continues to drift lower, it has become the accepted wisdom that we are headed for parity with read on...

article imageEmerging-Markets Stocks Took The Lead Last Week

Emerging-markets equities enjoyed a solid rise last week among the major asset classes, based on a set of read on...

article imageDoes Your Latest Investment Pass This Test?

On Wednesday, I sounded the alarm about the problems looming for some consumer staples stocks. In short, read on...

Popular Articles

Daily Sector Scan
Partner Center

Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.